Prilosec OTC Brandname Defended By P&G In Response To Petition
More than 90% of participants in Procter & Gamble's label comprehension studies for Prilosec OTC understood all warning statements, the firm states in Sept. 26 comments to FDA
More than 90% of participants in Procter & Gamble's label comprehension studies for Prilosec OTC understood all warning statements, the firm states in Sept. 26 comments to FDA